Drugplain

TUBERCULOSIS ELIMINATOR 50 mg/10g

ginsenoside compound k granule · GRANULE · Hainan Zehuitang Biotechnology Co., LTD

No Recall History
Plain English

TUBERCULOSIS ELIMINATOR is a granule containing ginsenoside compound k granule at 50 mg/10g, taken oral. Manufactured by Hainan Zehuitang Biotechnology Co., LTD.

Key Facts

Brand Name
TUBERCULOSIS ELIMINATOR
Generic Name
ginsenoside compound k granule
NDC Code (Product)
84428-105
Manufacturer
Hainan Zehuitang Biotechnology Co., LTD
Strength
50 mg/10g
Dosage Form
GRANULE
Route
ORAL
Marketing Status
Marketing Start
05/12/2025

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

swollen tongue1 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Use: Regulate the human immune system; Treat tuberculosis When using this productTake before mealsTake it half an hour before going to bed

Dosage & Administration

Directions: Take one bottle orally with water, three times daily. For internal use only.

Warnings

Warnings: Do not use if you are allergic to this product and its ingredients

Frequently Asked Questions

What is TUBERCULOSIS ELIMINATOR used for?

TUBERCULOSIS ELIMINATOR contains ginsenoside compound k granule. It is a granule taken oral. Consult your doctor for specific uses.

Is TUBERCULOSIS ELIMINATOR a controlled substance?

TUBERCULOSIS ELIMINATOR is not classified as a controlled substance by the DEA.

What is the generic name for TUBERCULOSIS ELIMINATOR?

The generic name for TUBERCULOSIS ELIMINATOR is ginsenoside compound k granule. There are no other listed brand versions of ginsenoside compound k granule.

What is the NDC code for TUBERCULOSIS ELIMINATOR 50 mg/10g?

The NDC (National Drug Code) for TUBERCULOSIS ELIMINATOR 50 mg/10g is 84428-105, listed by Hainan Zehuitang Biotechnology Co., LTD.

Product NDC

84428-105

Package NDC

84428-105-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)